Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellular Technology Services (CTS) was a specialized contract research organization (CRO) that provided high-end flow cytometry and cell-based assay services to the biopharmaceutical and healthcare industries. Based in Gaithersburg, Maryland, the company focused on supporting clinical trials through complex immunomonitoring, biomarker discovery, and bioanalytical testing. CTS was particularly recognized for its expertise in multi-color flow cytometry and its ability to handle large-scale clinical trial samples under GCLP standards. In 2014, the company was acquired by Eurofins Scientific to bolster its global bioanalytical service offerings, and its operations were integrated into Eurofins Pharma Bioanalytical Services. The company's legacy continues as a core component of Eurofins' immunology and cell therapy support capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellular Technical Services.